REQUEST A DEMO
Total
USD $0.00
Search more companies

Anvilab OOO (Анвилаб ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Anvilab OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Anvilab OOO (Анвилаб ООО) is a company based in Russia, with its head office in Sergiev Posad. It operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on January 12, 2007. It currently has a total number of 5 (2022) employees. From the latest financial highlights, Anvilab OOO (Анвилаб ООО) reported a net sales revenue increase of 87.48% in 2024. Its’ total assets recorded a growth of 17.05%. The net profit margin of Anvilab OOO (Анвилаб ООО) increased by 565.63% in 2024.

Headquarters
Festivalinaya, 10
Sergiev Posad; Moscow Oblast; Postal Code: 141307

Contact Details: Purchase the Anvilab OOO (Анвилаб ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Anvilab OOO (Анвилаб ООО) report to view the information.
Registered Capital:
Purchase the Anvilab OOO (Анвилаб ООО) report to view the information.
Financial Auditors:
Purchase the Anvilab OOO (Анвилаб ООО) report to view the information.
Incorporation Date:
January 12, 2007
Key Executives
Purchase this report to view the information.
General Director
Subsidiaries
Feniks OOO
15%
Company Performance
Financial values in the chart are available after Anvilab OOO (Анвилаб ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
87.48%
Total operating revenue
87.48%
Operating profit (EBIT)
85.62%
Net Profit (Loss) for the Period
93.89%
Total Assets
17.05%
Total Equity
-11.7%
Operating Profit Margin (ROS)
-0.22%
Net Profit Margin
565.63%
Return on Equity (ROE)
-173.4%
Debt/Equity
106.13%
Quick Ratio
-7.02%
Cash Ratio
-3.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?